<div>
  <p>
  </p>
  <ul>
    <li>
      <p>
        Hims &amp; Hers Health, an asynchronous store and forward service provider, has launched MedMatch, an AI-based technology to provide personalized healthcare.
      </p>
    </li>
    <li>
      <p>
        The new offering utilizes machine learning to analyze data collected by the company's platform to provide personalized and accurate healthcare recommendations for treatments and medications. MedMatch is currently in its beta testing phase and will initially be made available to patients seeking assistance with anxiety and depression.
      </p>
    </li>
    <li>
      <p>
        MedMatch functions primarily by leveraging anonymized historical customer data, including clinical visits, demographics, treatment types, and patient outcomes. By employing this Big Data, MedMatch can suggest optimal treatment options for individual patients in real-time.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.businesswire.com/news/home/20231106108871/en/Hims-Hers-Introduces-MedMatch-The-Next-Generation-of-Intelligent-Diagnostic-Services">
      Press release
    </a>
  </p>
  <p>
    <a href="https://hitconsultant.net/2023/11/06/hims-hers-launches-ai-service-to-help-providers-personalize-treatments/">
      HIT Consultant
    </a>
  </p>
  <p>
  </p>
</div>


Telehealth

DISRUPTOR_PRESENT

PROMINENT_CATEGORY

<div>
  <ul>
    <li>
      <p>Hims &amp; Hers Health has launched MedMatch, an AI-based technology that provides personalized healthcare recommendations.</p>
    </li>
    <li>
      <p>MedMatch uses machine learning to analyze data and give accurate healthcare suggestions.</p>
    </li>
    <li>
      <p>It is currently in beta testing and will be initially available for patients seeking help with anxiety and depression.</p>
    </li>
    <li>
      <p>MedMatch utilizes anonymized historical customer data to suggest treatment options in real-time.</p>
    </li>
  </ul>
</div>

Hims & Hers launches health personalization technology

Hims & Hers releases Q2 2023 results; surpasses expectations again; further revises guidance upward

Hims & Hers releases Q1 2023 results; surpasses expectations and revises guidance upward

Hims & Hers releases FY 2022 results, surpasses expectations for the year

Hims & Hers partners with ChristianaCare to expand care options in four states

Hims & Hers out performs Q3 2022 expectations, increases its earnings guidance upward for a third time

Hims’ topline grows 12% QoQ in Q2 2022; increases revenue guidance for 2022 yet again

Hims & Hers Health grows 20% QoQ in Q1 2022; ups revenue guidance for 2022

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

All Updates